SCHEMBL26231981

SCHEMBL26231981

c1cc(-n2c3ccccc3c3ccccc32)cc(-n2c3ccccc3c3cc4ccc5ccccc5c4cc32)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
HSD17B10 Q99714 4/20 0.52
CYP1B1 Q16678 2/20 0.52
HIF1A Q16665 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ATM Q13315 1/20 0.48
CYP1A2 P05177 4/20 0.41
HPGD P15428 3/20 0.41
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 2/20 0.39
CYP2A6 P11509 1/20 0.39
HPRT1 P00492 3/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
AHR P35869 1/20 0.36
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19769567 0.92 KDM4E (0.47) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL15821632 0.92 KDM4E (0.60) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL17864056 0.87 KDM4E (0.50) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL17228163 0.87 KDM4E (0.47) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL17736564 0.86 KDM4E (0.55) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL18177622 0.86 L3MBTL1 (0.67) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL12690798 0.86 KDM4E (0.64) ALDH1A1HSD17B10L3MBTL1KDM4EATM
SCHEMBL17228160 0.86 KDM4E (0.56) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL15823212 0.85 KDM4E (0.60) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL17228908 0.85 L3MBTL1 (0.60) ALDH1A1L3MBTL1KDM4EATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292612-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-09-14 US disclosed
US-20230292612-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292612-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 995/4885HSD17B10 3430/4885CYP1B1 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.